IFN-γ action on pancreatic beta cells causes class I MHC upregulation but not diabetes

Journal of Clinical Investigation

Volumn 102, Issue 6, 1998, Pages 1249-1257

  Thomas, Helen E ^a   Parker, Jennie L ^a   Schreiber, Robert D ^b   Kay, Thomas W H ^a,c  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b WASHINGTON UNIVERSITY   (United States)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Autoimmune disease; Class I major histocompatibility antigen; Cytokine; Nonobese diabetic mouse; Transgenic mice

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0032531099     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2899     Document Type: Article

References (53)

1. Rabinovitch, A., W. Suarez-Pinzon, A. El-Sheikh, O. Sorensen, and R.F. Power. 1996. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes. 45:749-754.
2. Rabinovitch, A., W.L. Suarez-Pinzon, O. Sorensen, R.C. Bleackley, and R.F. Power. 1995. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonohese diabetic mice. J. Immunol. 154:4874-4882.
3. Wang, B., I. Andre, A. Gonzalez, J.D. Katz, M. Aguet, C. Benoist, and D. Mathis. 1997. Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 94:13844-13849.
4. Campbell, I.L., T.W. Kay, L. Oxhrow, and L.C. Harrison. 1991. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87:734-742.
5. Debray-Sachs, M., C. Carnaud, C. Boitard, H. Cohen, I. Gresser, P. Bedossa, and J.F. Bach. 1991. Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4:237-248.
6. Nicoletti, F., P. Zaccone, R. Di Marco, M. Di Mauro, U. Magro, S. Grasso, L. Mughini, P. Meroni, and G. Garotta. 1996. The effects of a nonimmunogenic form of murine soluble interferon-gamma receptor on the development of autoimmune diabetes in the NOD mouse. Endocrinology. 137:5567-5575.
7. von Herrath, M.G., and M.B. Oldstone. 1997. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185:531-539.
8. Oldstone, M.B., M. Nerenberg, P. Southern, J. Price, and H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:319-331.
9. Ohashi, P.S., S. Oehen, K. Buerki, H. Pircher, C.T. Ohashi, B. Odermatt, B. Malissen, R.M. Zinkernagel, and H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:305-317.
10. Hultgren, B., X. Huang, N. Dyhdal, and T.A. Stewart. 1996. Genetic absence of gamma-interferon delays bul does not prevent diabetes in NOD mice. Diabetes. 45:812-817.
11. Eizirik, D.L., M. Flodstrom, A.E. Karlsen, and N. Welsh. 1996. The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia. 39:875-890.
12. Kaneto, H., J. Fujii, H.G. Seo, K. Suzuki, T. Matsuoka, M. Nakamura, H. Tatsumi, Y. Yamasaki, T. Kamada, and N. Taniguchi. 1995. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes. 44:733-738.
13. Dunger, A., J.M. Cunningham, C.A. Delaney, J.E. Lowe, M.H. Green, A.J. Bone, and I.C. Green. 1996. Tumor necrosis factor-alpha and interferon-gamma inhibit insulin secretion and cause DNA damage in unweaned-rat islets. Extent of nitric oxide involvement. Diabetes. 45:183-189.
14. Corbett, J.A., and M.L. McDaniel. 1995. Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase. J. Exp. Med. 181:559-568.
15. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267: 1449-1456.
16. Yamada, K., N. Takane-Gyotoku, X. Yuan, F. Ichikawa, C. Inada, and K. Nonaka. 1996. Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia. 39:1306-1312.
17. Yagi, N., K. Yokono, K. Amano, M. Nagata, K. Tsukamoto, Y. Hasegawa, R. Yoneda, N. Okamoto, H. Moriyama, M. Miki, et al. 1995. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T cells in murine autoimmune diabetes. Diabetes. 44:744-752.
18. Hanninen, A., S. Jalkanen, M. Salmi, S. Toikkanen, G. Nikolakaros, and O. Simell. 1992. Macrophages. T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J. Clin. Invest. 90:1901-1910.
19. Itoh, N., T. Hanafusa, A. Miyazaki, J. Miyagawa, K. Yamagata, K. Yamamoto, M. Waguri, A. Imagawa, S. Tamura, M. Inada, et al. 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92:2313-2322.
20. Somoza, N., F. Vargas, C. Roura-Mir, M. Vives-Pi, M.T. Fernandez-Figueras, A. Ariza, R. Gomis, R. Bragado, M. Marti, D. Jaraquemada, and R. Pujol-Borrell. 1994. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA. adhesion molecules and autoantigens, restricted T cell re-ceptor V beta usage, and cytokine profile. J. Immunol. 153:1360-1377.
21. Kay, T.W., I.L. Campbell, L. Oxbrow, and L.C. Harrison. 1991. Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia. 34:779-785.
22. O'Reilly, L.A., P.R. Hutchings, P.R. Crocker, E. Simpson, T. Lund, D. Kioussis, F. Takei, J. Baird, and A. Cooke. 1991. Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur.J. Immunol. 21:1171-1180.
23. Ono, SJ., B. Issa-Chergui, E. Colle, R.D. Guttmann, T.A. Seemayer, and A. Fuks. 1988. IDDM in BB rats. Enhanced MHC class I heavy-chain gene expression in pancreatic islets. Diabetes. 37:1411-1418.
24. Ohashi, P.S., S. Oehen, P. Aichele, H. Pircher, B. Odermatt, P. Herrera, Y. Higuchi, K. Buerki, H. Hengartner, and R.M. Zinkcrnagel. 1993. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. J. Immunol. 150:5185-5144.
25. Vives-Pi, M., M.P. Armengol, L. Alcalde, M. Costa, N. Somoza, F. Vargas, D. Jaraquemada, and R. Pujol-Borrell. 1996. Expression of transporter associated with antigen processing-1 in the endocrine cells of human pancreatic islets: effect of cytokines and evidence of hyperexpression in IDDM. Diabetes. 45:779-788.
26. Wicker, L.S., E.H. Leiter, J.A. Todd, R.J. Renjilian, E. Peterson, P.A. Fischer, P.L. Podolin, M. Zijlstra, R. Jaenisch, and L.B. Peterson. 1994. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 43:500-504.
27. Scrreze, D.V., E.H. Leiter, G.J. Christianson, D. Greiner, and D.C. Roopenian. 1994. Major histocompatibility complex class I-deficient NOD-B2mnull mice arc diabetes and insulitis resistant. Diabetes. 43:505-509.
28. Sumida, T., M. Furukawa, A, Sakamoto, T. Namekawa, T. Maeda, M. Zijlstra, I. Iwamoto, T. Koike, S. Yoshida, H. Tomioka, and M. Taniguchi. 1994. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int. Immunol. 6:1445-1449.
29. Katz, J., C. Benoist, and D. Mathis. 1993. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.Eur. J. Immunol. 23:3358-3360.
30. Raulet, D.H. 1994. MHC class I-deficient mice. Adv. Immunol. 55:381-421.
31. Kay, T.W., J.L. Parker, L.A. Stephens, H.E. Thomas, and J. Allison. 1996. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J. Immunol. 157: 3688-3693.
32. Kurts, C., W.R. Heath, F.R. Carbone, J. Allison. J.F. Miller, and H. Kosaka. 1996. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
33. Dighe, A.S., D. Campbell, C.S. Hsieh, S. Clarke, D.R. Greaves, S. Gordon, K.M. Murphy, and R.D. Schreiber. 1995. Tissue-specific targeting of cytokine unresponsiveness in transgenic mice. Immnnity. 3:657-666.
34. Dighe, A.S., M.A. Farrar, and R.D. Schreiber. 1993. Inhibition of cellular responsiveness to interferon-gamma (IFN gamma) induced by overexpression of inactive forms of the IFN gamma receptor. J. Biol. Chem. 268:10645-10653.
35. Dietrich, W.F., J. Miller, R. Steen, M.A. Merchant, D. Damron-Boles, Z. Husain, R. Dredge, M.J. Daly, K.A. Ingalls, et al. 1996. A comprehensive genetic map of the mouse genome. Nature. 380:149-152.
36. Church, G.M., and S. Kieffer-Higgins. 1988. Multiplex DNA sequencing. Science. 240:185-188.
37. Richterich, P., and G.M. Church. 1993. DNA sequencing with direct transfer electrophoresis and nonradioactive detection. Methods Enzymol. 218: 187-222.
38. Lake, S.P., J. Anderson, J. Chamberlain, S.J. Gardner, P.R. Bell, and R.F. James. 1987. Bovine serum albumin density gradient isolation of rat pancreatic islets. Transplantation. 43:805-808.
39. Evan, G.I., O.K. Lewis, G. Ramsay, and J.M. Bishop. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5:3610-3616.
40. LeClaire, R.D., M. Basu, D.M. Pinson, M.L. Redick, J.S. Hunt, P.J. Zavodny, J.L. Pace, and S.W. Russell. 1992. Characterization and use of monoclonal and polyclonal antibodies against the mouse interferon-gamma receptor. J. Leukoc. Biol. 51:507-516.
41. Ozato, K., N.M. Mayer, and D.H. Sachs. 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation. 34:113-120.
42. Eisenharth, G.S., F.S. Walsh, and M. Nirenberg. 1979. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA. 76: 4913-4917.
43. Pipeleers, D.G., P.A. in't Veld, M. Van de Winkel, E. Maes, F.C. Schuit, and W. Gepts. 1985. A new in vitro model for the study of pancreatic A and B cells. Endocrinology. 117:806-816.
44. Schreiber, E., P. Matthias. M.M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
45. Pearse, R.N., R. Feinman, K. Shuai, J. Darnell, Jr., and J.V. Ravetch. 1993. Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc. Natl. Acad. Sci. USA. 90:4314-4318.
46. Charlton, B., and T.E. Mandel. 1988. Progression from insulitis to beta-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes. 37: 1108-1112.
47. Darnell, J., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415-1421.
48. Rabinovitch, A. 1996. Roles of cell-mediated immunity and cytokines in the pathogenesis of insulin-dependent diabetes mellilus. In Diabetes Mellitus-A Fundamental and Clinical Text. D. LeRoith, S.I. Taylor, and J.M. Olefsky, editors. Lippincott-Raven Publishers. Philadelphia. 314-325.
49. Pankewycz, O.G., J.X. Guan, and J.F. Benedict. 1995. Cytokines as mediators of autoimmune diabetes and diabetic complications. Endocr. Rev. 16: 164-176.
50. Harrison, L.C., I.L. Campbell, P.G. Colman, N. Chosich, T.W.H. Kay, B.D. Tait, R.K. Bartholomeusz, H.J. De Aizpurua, J.L. Joseph, S. Chu, and W.E. Kielczynski. 1990. Type 1 diabetes: immune-pathology and immunotherapy. Adv. Endocrinol. Metab. 1:35-94.
51. Kay, T., H.L. Chaplin, J.L. Parker, L.A. Stephens, and H.E. Thomas. 1997. CD4(+) and CD8(+) T lymphocytes - clarification of their pathogenic roles in diabetes in the NOD mouse. Res. Immunol. 148:320-327.
52. Swihart, K., U. Fruth, N. Messmer, K. Hug, R. Behin, S. Huang, G. Del Giudice, M. Aguet, and J.A. Louis. 1995. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 181:961-971.
53. Hamaguchi, K., H.R. Gaskins, and E.H. Leiter. 1991. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes. 40: 842-849.